Trine Lindsted
6Patents
1h-index
20Co-inventors
47Inventor score
Filing activity: Oct 12, 2010 → Apr 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7947653B1 | Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers | Human Necessities | 7 | Active |
| US8323883B1 | Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors | Physics | 1 | Active |
| US11390674B2 | Anti-TIM-3 antibodies and compositions | Chemistry; Metallurgy | 1 | Active |
| US11939380B2 | Combination therapies targeting PD-1, TIM-3, and LAG-3 | Emerging Cross-Sectional Technologies | 0 | Active |
| US11807688B2 | Anti-AXL antibodies and compositions | Chemistry; Metallurgy | 0 | Active |
| US12252539B2 | Anti-FLT3 antibodies and compositions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.